Al convegno della Societá Italiana di Farmacologia del 25 – 28 ottobre pv a Rimini si parlerá di nuove prospettive terapeutiche per l’autismo incentrate soprattutto sul sistema cannabinoide http://congresso.sifweb.org/ 16.30-18.30 SYMPOSIUM THE ENDOCANNABINOID SYSTEM AND AUTISM SPECTRUM DISORDERS Chairpersons: Daniela Parolaro (Milan) - Marie Woolley (London - UK) Targeting anandamide metabolism rescues autistic-like symptoms in rats prenatally exposed to valproic acid Viviana Trezza (Rome) The non-psychotropic plant cannabinoid cannabidivarin ameliorates Rett syndrome-like phenotype in methyl CpG binding protein 2 (MeCP2) mutant mice Erica Zamberletti (Busto Arsizio) The endocannabinoid system as therapeutic target for fragile X syndrome and other cognitive disorders Rafael Maldonado (Barcelona – Spain) Endocannabinoid system dysregulation drives inflammatory state and human immune system cell alterations in autism spectrum disorders Dario Siniscalco (Naples) Changes in the endocannabinoid system underlie the altered social behavior observed in a rat model of autism spectrum disorders Melancia F., Servadio M., Schiavi S., Manduca A., Cartocci V., Pallottini V., Trezza V Chronic cannabidivarin administration rescues autism-like behaviors induced by prenatal valproic acid exposure in male offspring Gabaglio M., Zamberletti E., Piscitelli F., Rubino T., Di Marzo V., Parolaro D Behavioral and metabolic characterization of a mouse model of autism spectrum disorder and a possible therapeutic effect of palmitoylethanolamide Cristiano C., Coretti L., Lama A., Russo R., Mattace Raso G., Lembo F., Chiariotti L., Meli R., Calignano A. http://www.archiviosif.org/eventi/2017/sif_38_cong_naz_rimini_2017_prog.pdf Daniela Mariani Cerati